Stock Trading Canary

United States · SEC Form 4 · Snapshot date: 2026-10-18 · Built: 2026-10-18 · 中文

← United States · Coverage record

US · SEC FORM 4

Candel Therapeutics, Inc.

CADL · Nasdaq · CIK 0001841387 · Healthcare · Biotechnology

INSIDER SIGNAL

No active buy signal

0 qualifying P purchase groups
in the current 180-day scoring window

6 Form 4 transaction lines observed in the same window
5 sales · 1 option, withholding, award, gift or other lines

Last qualifying purchase2026-02-23 · Manning Paul B · $3.0M

WHY NO ACTIVE SIGNAL?

Purchase activityNone
Recent buyingNone
Recent salesModerate
Buy signal statusInactive
Score anatomy

No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.

ClusterNot calculated
Purchase sizeNot calculated
RoleNot calculated
RecencyNot calculated
ConvictionNot calculated

Why is there no score?

  • No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
  • Sales and other Form 4 activity remain visible as context and do not create a negative score.

Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.

Insider activity timeline

Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.

AprMayJunJulAugSepOct
Tak Paul PeterChief Executive Officer
○▼▼
Tyagarajan SeshuChief Technology Officer
▼▼
Barone FrancescaChief Scientific Officer
▼
● Purchase▼ Sale○ Other

—

Purchase breadth, concentration & cluster buying

These modules activate when qualifying purchases enter the 180-day research window.

SIGNAL HISTORY

No recorded active-signal snapshot

Scores are archived only when the company qualifies for a published US buy-signal snapshot. Last qualifying purchase: 2026-02-23 · Manning Paul B.

Recent Form 4 activity

1Purchases
5Sales
1Other Form 4 lines
5SEC filings · 365 days
BUYING0 qualifying P line(s) · 180 days
SELLING5 sale line(s) · context only
OTHER1 exercise / withholding / award / gift / other lines
10b5-1 / PLANNEDNot assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

Market context

Market context has not been captured for this ticker yet. The daily market-context job processes the US universe in rotating batches.

Short interest

Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.

Shares short
13,000,504
Previous report
12,344,649
Avg daily volume
1,165,450
Days to cover
11.2

FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.

Historical equity purchases

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting ownerTypeSecuritySharesAvg. priceApprox. valueSource
2026-02-23Manning Paul BPurchase (P)Common Stock550,458USD 5.45USD 2,999,996SEC filing ↗
2024-12-16Manning Paul BPurchase (P)Common Stock1,250,000USD 6.00USD 7,500,000SEC filing ↗
2022-12-09Martell ChristopherPurchase (P)Common Stock23,950USD 1.92USD 45,984SEC filing ↗
2022-12-09Tyagarajan SeshuPurchase (P)Common Stock10,358USD 1.93USD 19,991SEC filing ↗
2022-12-09Tak Paul PeterPurchase (P)Common Stock12,935USD 1.92USD 24,835SEC filing ↗
2022-12-09PAPA JOSEPH CPurchase (P)Common Stock35,018USD 1.94USD 67,935SEC filing ↗
2022-12-09Martell ChristopherPurchase (P)Common Stock23,950USD 1.92USD 45,984SEC filing ↗
2022-12-09Amello JasonPurchase (P)Common Stock2,468USD 1.93USD 4,763SEC filing ↗
2022-12-08Martell ChristopherPurchase (P)Common Stock3,050USD 1.68USD 5,124SEC filing ↗
2022-12-08Tyagarajan SeshuPurchase (P)Common Stock3,000USD 1.69USD 5,070SEC filing ↗
2022-12-08Tak Paul PeterPurchase (P)Common Stock3,050USD 1.70USD 5,185SEC filing ↗
2022-12-08PAPA JOSEPH CPurchase (P)Common Stock3,014USD 1.70USD 5,124SEC filing ↗
2022-12-08Martell ChristopherPurchase (P)Common Stock3,050USD 1.68USD 5,124SEC filing ↗
2022-12-08Barone FrancescaPurchase (P)Common Stock1,238USD 1.61USD 1,993SEC filing ↗
2022-12-08Amello JasonPurchase (P)Common Stock3,100USD 1.69USD 5,239SEC filing ↗

Form 4 evidence

7 transaction lines in the latest 365-day window; 136 in local history.

DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-09-11Tak Paul PeterSale (S)Common Stock59,379USD 10.46USD 621,104SEC filing ↗
2026-09-10Tak Paul PeterSale (S)Common Stock220,866USD 11.50USD 2,539,959SEC filing ↗
2026-09-10Tak Paul PeterOption exercise / conversion (M)Common Stock125,000USD 1.55USD 193,750SEC filing ↗
Show recent Form 4 evidence (7 grouped rows)
DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-09-11Tak Paul PeterSale (S)Common Stock59,379USD 10.46USD 621,104SEC filing ↗
2026-09-10Tak Paul PeterSale (S)Common Stock220,866USD 11.50USD 2,539,959SEC filing ↗
2026-09-10Tak Paul PeterOption exercise / conversion (M)Common Stock125,000USD 1.55USD 193,750SEC filing ↗
2026-08-17Tyagarajan SeshuSale (S)Common Stock7,000USD 12.00USD 84,000SEC filing ↗
2026-06-29Tyagarajan SeshuSale (S)Common Stock7,000USD 10.02USD 70,140SEC filing ↗
2026-06-29Barone FrancescaSale (S)Common Stock23,447USD 10.06USD 235,877SEC filing ↗
2026-02-23Manning Paul BPurchase (P)Common Stock550,458USD 5.45USD 2,999,996SEC filing ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

Snapshot & identity

Snapshot date2026-10-18
Ranking versionUS-v1.2
Data qualityPASS ELIGIBLE · —
TickerCADL
CIK0001841387
SectorHealthcare
IndustryBiotechnology Yahoo Finance
SEC SIC2836 Biological Products, (No Diagnostic Substances)
ExchangeNasdaq

Data coverage

Local Form 4 history136 transaction lines from 2021-07-14 to 2026-09-11
24 P purchase lines · 44 S sale lines · 68 other lines
SEC company submissionsOpen SEC filings ↗

Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.